ArticleInvestigational new drugs2017

Phase Ib study of the mitochondrial inhibitor ME-344 plus topotecan in patients with previously treated, locally advanced or metastatic small cell lung, ovarian and cervical cancers.

Jennifer R Diamond et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.